Public Comment of Members of the Patient, Consumer, and Public Health Coalition on National Coverage Analysis for Transcatheter Aortic Valve Replacement (TAVR)
Members of the Patient, Consumer, and Public Health Coalition urge CMS to reject a National Coverage Determination for TAVR in asymptomatic patients, citing insufficient evidence of benefit for Medicare beneficiaries. The comment raises concerns about patient safety, trial limitations, valve durability, and responsible use of Medicare resources.
